A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)
Clinical trial NCT00551213 · COMPLETED
Trial details
- NCT number
- NCT00551213
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-21
- Primary completion
- 2009-06-04
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.